SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
Deals
CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals
November 19, 2019
 · 
3 min read
Deals
CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock at $4.00 per share
November 13, 2019
 · 
2 min read
Deals
CNS Pharmaceuticals Announces Pricing Of Initial Public Offering
November 7, 2019
 · 
1 min read
Job Trends
Breakthrough Cancer Technology To Be Funded By The Crowd
March 20, 2018
 · 
6 min read
Pharm Country
CNS PHARMACEUTICALS AG Announces Brain Fizz(TM) -- A New Powder Formulation of MemorA-Z(R)
April 13, 2010
 · 
2 min read
Business
CNS PHARMACEUTICALS AG Retains Jumpstart Marketing, Inc. to Launch Marketing Campaign
March 25, 2010
 · 
2 min read
Business
Genetics Policy Institute (GPI) Engages 886 AG as Designated Sponsor
November 13, 2009
 · 
1 min read
Pharm Country
CNS PHARMACEUTICALS AG Launches New Website
July 9, 2009
 · 
1 min read
Load More
JOBS